S-1 and Cisplatin versus Docetaxel and Cisplatin in Patients with Untreated Advanced NSCLC: An Randomised, Multicenter, Phase 3 Trial

被引：0

作者：

Shi, Yuankai ^{[1
,2
]}

Wang, Mengzhao ^{[3
]}

He, Jianxing ^{[4
]}

Chang, Jianhua ^{[5
]}

Han, Baohui ^{[6
]}

Liu, Xiaoqing ^{[7
]}

Chen, Gongyan ^{[8
]}

Zhou, Caicun ^{[9
]}

Liu, Jiwei ^{[10
]}

Pan, Hongming ^{[11
]}

Huang, Cheng ^{[12
]}

Zhang, Shucai ^{[13
]}

Feng, Jifeng ^{[14
]}

Lin, Xiaoyan ^{[15
]}

Wang, Jie ^{[16
]}

Huang, Jianjin ^{[17
]}

Li, Fang ^{[18
]}

Qin, Shukui ^{[19
]}

Wang, Zhehai ^{[20
]}

Wang, Liwei ^{[21
]}

Xu, Nong ^{[22
]}

机构：

[1] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing 100730, Peoples R China

[2] Peking Union Med Coll, Natl Ctr Anticanc Drugs Clin Study, Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing 100021, Peoples R China

[3] Beijing Union Med Coll Hosp, Beijing, Peoples R China

[4] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China

[5] Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China

[6] Shanghai Chest Hosp, Shanghai, Peoples R China

[7] Acad Mil Med Sci, Affiliated Hosp, Beijing, Peoples R China

[8] Harbin Med Univ, Affiliated Tumor Hosp, Harbin, Peoples R China

[9] Shanghai Pulm Hosp, Shanghai, Peoples R China

[10] Dalian Med Univ, Affiliated Hosp 1, Dalian, Peoples R China

[11] Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China

[12] Fujian Prov Tumor Hosp, Fuzhou, Peoples R China

[13] Beijing Chest Hosp, Beijing, Peoples R China

[14] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China

[15] Fujian Med Univ, Union Hosp, Fuzhou, Peoples R China

[16] Beijing Canc Hosp, Beijing, Peoples R China

[17] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China

[18] Chinese Peoples Liberat Army Gen Hosp, Beijing 100853, Peoples R China

[19] 81 Hosp PeopleS Liberat Army, Nanjing, Peoples R China

[20] Shandong Canc Hosp, Jinan, Peoples R China

[21] Shanghai First PeopleS Hosp, Shanghai, Peoples R China

[22] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China

来源：

JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期

关键词：

S-1; phase; 3; trial; Therapy; NSCLC;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ORAL01.06

引用

页码：S174 / S174

页数：1

共 50 条

[31] S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial
Kang, Yoon-Koo
Chin, Keisho
Chung, Hyun Cheol
Kadowaki, Shigenori
Oh, Sang Cheul
Nakayama, Norisuke
Lee, Keun-Wook
Hara, Hiroki
Chung, Ik-Joo
Tsuda, Masahiro
Park, Se Hoon
Hosaka, Hisashi
Hironaka, Shuichi
Miyata, Yoshinori
Ryu, Min-Hee
Baba, Hideo
Hyodo, Ichinosuke
Bang, Yung-Jue
Boku, Narikazu
LANCET ONCOLOGY, 2020, 21 (08): : 1045 - 1056
[32] A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial
Kubota, K.
Sakai, H.
Katakami, N.
Nishio, M.
Inoue, A.
Okamoto, H.
Isobe, H.
Kunitoh, H.
Takiguchi, Y.
Kobayashi, K.
Nakamura, Y.
Ohmatsu, H.
Sugawara, S.
Minato, K.
Fukuda, M.
Yokoyama, A.
Takeuchi, M.
Michimae, H.
Gemma, A.
Kudoh, S.
ANNALS OF ONCOLOGY, 2015, 26 (07) : 1401 - 1408
[33] A phase I/II study of S-1 plus cisplatin alternating with S-1 plus docetaxel in patients with advanced gastric cancer (AGC)
Hosokawa, A.
Ogawa, K.
Kajiura, S.
Tsukioka, Y.
Kobayashi, T.
Horikawa, N.
Kobayashi, Y.
Yoshioka, A.
Sumi, S.
Sugiyama, T.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
[34] A phase III study of S-1 plus cisplatin versus fluorouracil plus cisplatin in patients with advanced gastric or gastroesophageal junction adenocarcinoma
Xu, Rui-hua
Sun, Guo-ping
Lu, Hui-shan
Peng, Liu Yun
Xu, Jian-ming
Zhong, Mei-zuo
Zhang, He-long
Yu, Shi-ying
Li, Wei
Hu, Xiao-hua
Wang, Jie Jun
Cheng, Ying
Zhou, Jun-tian
Guo, Zeng-qing
Guan, Zhongzhen
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[35] A Randomized Phase 2 Study of Docetaxel and S-1 Versus Docetaxel and Cisplatin in Advanced Gastric Cancer With an Evaluation of SPARC Expression for Personalized Therapy
Jeung, Hei-Cheul
Rha, Sun Young
Im, Chong Kun
Shin, Sang Joon
Ahn, Joong Bae
Yang, Woo Ick
Roh, Jae Kyung
Noh, Sung Hoon
Chung, Hyun Cheol
CANCER, 2011, 117 (10) : 2050 - 2057
[36] Phase II trial of concurrent chemoradiotherapy with S-1 versus weekly cisplatin for locoregionally advanced nasopharyngeal carcinoma
Wen, Linchun
You, Chuanwen
Lu, Xiyan
Zhang, Longzhen
MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (03) : 687 - 691
[37] Phase Ⅰ trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer
Akinori Watanabe
Mitsuhiro Kida
Shiro Miyazawa
Tomohisa Iwai
Kosuke Okuwaki
Toru Kaneko
Hiroshi Yamauchi
Miyoko Takezawa
Hiroshi Imaizumi
Wasaburo Koizumi
World Journal of Gastroenterology, 2015, (19) : 5979 - 5984
[38] S-1 PLUS CISPLATIN VERSUS DOCETAXEL PLUS CISPLATIN IN CHEMOTHERAPY-NAIVE PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER: A RANDOMIZED, MULTICENTER PHASE III STUDY (TCOG0701)
Niho, S.
Gemma, A.
Sakai, H.
Kubota, K.
Nishio, M.
Inoue, A.
Okamoto, H.
Isobe, H.
Kunitoh, H.
Takiguchi, Y.
Kobayashi, K.
Nakamura, Y.
Katakami, N.
Takeuchi, M.
Kudoh, S.
ANNALS OF ONCOLOGY, 2012, 23 : 34 - 34
[39] Efficacy and tolerability of docetaxel and cisplatin plus S-1 for advanced gastric cancer
Luo, Haiqing
Yu, Zhonghua
Gao, Hongfei
Guan, Chengnong
Xu, Meng
JOURNAL OF BUON, 2013, 18 (01): : 154 - 161
[40] Phase I trial of combination chemotherapy with docetaxel, cisplatin and S-1 (TPS) in patients with locally advanced or recurrent/metastatic head and neck cancer
Tahara, M.
Araki, K.
Okano, S.
Kiyota, N.
Fuse, N.
Minashi, K.
Yoshino, T.
Doi, T.
Zenda, S.
Kawashima, M.
Ogino, T.
Hayashi, R.
Minami, H.
Ohtsu, A.
ANNALS OF ONCOLOGY, 2011, 22 (01) : 175 - 180

← 1 2 3 4 5 →